BackBRIM Biotechnology Overview

BRIM Biotechnology Current Cash

Track BRIM Biotechnology's current cash ($800M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$798.43M
↑ 58.81% YoYΔ $295.67M vs prior year quarter

Peer trimmed avg / median

Loading

BRIM Biotechnology Current Cash History

Loading

BRIM Biotechnology vs. peers: Current Cash Comparison

Loading

BRIM Biotechnology Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

BRIM Biotechnology (6885.TWO) FAQ

As of the most recent data (December 2025), 6885.TWO shows a current cash of $800M. That compares with $500M in the prior-year period — up 58.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6885.TWO's current cash is now $800M (was $500M) — a 58.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether BRIM Biotechnology is outperforming or lagging.

Tracking 6885.TWO's current cash over time shows whether BRIM Biotechnology is scaling, shrinking, or reshaping that part of the business. The current reading is $800M That compares with $500M in the prior-year period — up 58.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has BRIM Biotechnology's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $800M) with ownership activity and broader fundamentals.

BRIM Biotechnology's current cash is $800M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.